Biological response modifiers in the management of patients with breast cancer
- 1 September 1990
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 16 (2) , 67-87
- https://doi.org/10.1007/bf01809291
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrowBreast Cancer Research and Treatment, 1988
- Gene products which play a role in cancer invasion and metastasisBreast Cancer Research and Treatment, 1988
- Active immunization to luteinizing hormone releasing hormone to inhibit the induction of mammary tumors in the ratLife Sciences, 1988
- Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor PrognosisNew England Journal of Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Modulation of the immune system by synthetic polynucleotidesSpringer Seminars in Immunopathology, 1979